Corcept Therapeutics Overview
- Founded
- 1998

- Status
- Public
- Employees
- 206

- Stock Symbol
- CORT

- Share Price
- $28.14
- (As of Friday Closing)
Corcept Therapeutics General Information
Description
Corcept Therapeutics Inc is engaged in the discovery, development, and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders by modulating the effects of cortisol.
Contact Information
- 149 Commonwealth Drive
- Menlo Park, CA 94025
- United States
Corcept Therapeutics Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$28.14 | $27.62 | $9.70 - $28.36 | $3.27B | 116M | 939K | $0.96 |
Corcept Therapeutics Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
---|---|---|---|---|
EV | 1,609,428 | 1,151,922 | 1,347,509 | 1,985,926 |
Revenue | 356,034 | 306,486 | 251,247 | 159,201 |
EBITDA | 134,944 | 113,777 | 89,732 | 52,961 |
Net Income | 109,398 | 94,181 | 75,410 | 129,122 |
Total Assets | 534,125 | 412,312 | 311,694 | 220,537 |
Total Debt | 3,031 | 3,461 | 0 | 0 |
Corcept Therapeutics Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Corcept Therapeutics‘s full profile, request access.
Request a free trialCorcept Therapeutics Comparisons
Industry
0000 000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialCorcept Therapeutics Competitors (16)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
SAGE Therapeutics | Formerly VC-backed | Cambridge, MA | 000 | 00.000 | 000000000 | 00.000 |
000000000 00000000 | Corporation | Pasadena, CA | 000 | 00.000 | 000000 - 000 | 00.000 |
000000000000 | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 000000000 | 00000 |
000000000 00000000 | Formerly VC-backed | Cambridge, MA | 00 | 00000 | 000000 - 000 | 00000 |
00000000 000000000 | Formerly VC-backed | Ann Arbor, MI | 000 | 00000 | 00000000000 | 00000 |
Corcept Therapeutics Executive Team (7)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Joseph Belanoff MD | Chief Executive Officer & Founder | ||
Charles Robb JD | Chief Financial Officer | ||
Hazel Hunt Ph.D | Director, Research | ||
Daniel Bradbury | Independent Director |
Corcept Therapeutics Board Members (9)
Name | Representing | Role | Since |
---|---|---|---|
Daniel Swisher Jr. | Self | Board Member | 000 0000 |
David Mahoney | Self | Board Member | 000 0000 |
George Baker Jr. | Self | Board Member | 000 0000 |
Gregg Alton JD | Corcept Therapeutics | Board Member | 000 0000 |
James Wilson | Self | Chairman & Board Member | 000 0000 |
Corcept Therapeutics Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial